
    
      The purpose of this study is to evaluate the efficacy of 300 mg/day of topiramate for the
      treatment of 200 treatment-seeking alcohol dependent outpatients with comorbid cocaine
      dependence in a double-blind, placebo-controlled 14-week trial, with a 6-month follow-up (3
      months after completing medications).
    
  